| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |